China · Delayed Price · Currency is CNY Jiangsu Nanfang Medical Statistics
Total Valuation
SHA:603880 has a market cap or net worth of CNY 2.85 billion. The enterprise value is 3.23 billion.
| Market Cap | 2.85B |
| Enterprise Value | 3.23B |
Important Dates
The last earnings date was Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:603880 has 289.04 million shares outstanding. The number of shares has decreased by -3.25% in one year.
| Current Share Class | 289.04M |
| Shares Outstanding | 289.04M |
| Shares Change (YoY) | -3.25% |
| Shares Change (QoQ) | +9.71% |
| Owned by Insiders (%) | 52.42% |
| Owned by Institutions (%) | 4.92% |
| Float | 137.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.05 |
| PB Ratio | 17.45 |
| P/TBV Ratio | 23.89 |
| P/FCF Ratio | 202.75 |
| P/OCF Ratio | 177.07 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 229.70 |
Financial Position
The company has a current ratio of 0.45, with a Debt / Equity ratio of 2.65.
| Current Ratio | 0.45 |
| Quick Ratio | 0.25 |
| Debt / Equity | 2.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | 30.78 |
| Interest Coverage | -9.72 |
Financial Efficiency
Return on equity (ROE) is -48.64% and return on invested capital (ROIC) is -14.99%.
| Return on Equity (ROE) | -48.64% |
| Return on Assets (ROA) | -5.50% |
| Return on Invested Capital (ROIC) | -14.99% |
| Return on Capital Employed (ROCE) | -35.32% |
| Weighted Average Cost of Capital (WACC) | 5.93% |
| Revenue Per Employee | 716,455 |
| Profits Per Employee | -135,025 |
| Employee Count | 789 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 3.77 |
Taxes
In the past 12 months, SHA:603880 has paid 7.65 million in taxes.
| Income Tax | 7.65M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.31% in the last 52 weeks. The beta is 0.43, so SHA:603880's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +55.31% |
| 50-Day Moving Average | 7.94 |
| 200-Day Moving Average | 7.21 |
| Relative Strength Index (RSI) | 61.48 |
| Average Volume (20 Days) | 14,579,628 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603880 had revenue of CNY 565.28 million and -106.53 million in losses. Loss per share was -0.36.
| Revenue | 565.28M |
| Gross Profit | 11.21M |
| Operating Income | -81.94M |
| Pretax Income | -98.12M |
| Net Income | -106.53M |
| EBITDA | -33.12M |
| EBIT | -81.94M |
| Loss Per Share | -0.36 |
Balance Sheet
The company has 57.95 million in cash and 433.06 million in debt, with a net cash position of -375.11 million or -1.30 per share.
| Cash & Cash Equivalents | 57.95M |
| Total Debt | 433.06M |
| Net Cash | -375.11M |
| Net Cash Per Share | -1.30 |
| Equity (Book Value) | 163.51M |
| Book Value Per Share | 0.51 |
| Working Capital | -355.88M |
Cash Flow
In the last 12 months, operating cash flow was 16.11 million and capital expenditures -2.04 million, giving a free cash flow of 14.07 million.
| Operating Cash Flow | 16.11M |
| Capital Expenditures | -2.04M |
| Depreciation & Amortization | 48.82M |
| Net Borrowing | 5.05M |
| Free Cash Flow | 14.07M |
| FCF Per Share | 0.05 |
Margins
Gross margin is 1.98%, with operating and profit margins of -14.49% and -18.85%.
| Gross Margin | 1.98% |
| Operating Margin | -14.49% |
| Pretax Margin | -17.36% |
| Profit Margin | -18.85% |
| EBITDA Margin | -5.86% |
| EBIT Margin | -14.49% |
| FCF Margin | 2.49% |
Dividends & Yields
SHA:603880 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.25% |
| Shareholder Yield | 3.25% |
| Earnings Yield | -3.73% |
| FCF Yield | 0.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 21, 2021. It was a forward split with a ratio of 1.3.
| Last Split Date | May 21, 2021 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |